Clinical Trials for Renal Cell Carcinoma

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

NCT ID: NCT04981509

This clinical trial is investigating a combination treatment using three medications—bevacizumab, erlotinib, and atezolizumab—for patients with advanced kidney cancer. The goal is to see if this co...

Evaluation of a Simple-Prep Controlled Embolic

NCT ID: NCT06453642

This clinical trial is testing a new device called the GPX® Embolic Device, which is designed to block blood flow to certain areas in the body, a process known as embolization. The goal is to see h...

Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)

NCT ID: NCT05721222

This clinical trial, called PRO1160-001, is researching a new drug named PRO1160 for patients with advanced solid tumors or certain types of blood cancers, specifically Renal Cell Carcinoma (a type...

Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy

NCT ID: NCT05703269

This clinical trial is looking to find out whether giving a lower dose of radiation over several days (called fractionated stereotactic radiosurgery, or FSRS) is better at reducing side effects com...

A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

NCT ID: NCT04260802

This clinical trial is investigating a new treatment called OC-001 for patients with advanced or spreading cancers, including types like triple-negative breast cancer, gastric cancer, and non-small...

Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders

NCT ID: NCT00001238

This clinical trial is focused on studying inherited kidney cancers and other related urologic disorders. Researchers want to understand how these conditions affect individuals and their families, ...

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

NCT ID: NCT05783622

This clinical trial is studying a new treatment called JANX008 for adults with advanced or metastatic solid tumors, such as certain types of lung cancer, kidney cancer, and breast cancer. The aim i...

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

NCT ID: NCT06053658

This clinical trial is exploring whether a combination of two medications, tivozanib and nivolumab, can help control advanced non-clear cell renal cell carcinoma (nccRCC), a type of kidney cancer. ...

Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor

NCT ID: NCT03093688

This clinical trial is testing a new treatment for people with advanced cancers such as lung, pancreatic, liver, stomach, and kidney cancers. The treatment involves giving patients special immune c...

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

NCT ID: NCT00102544

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

NCT ID: NCT07049926

This clinical trial is studying new combination treatments for people with a type of kidney cancer called clear cell renal cell carcinoma (ccRCC) that has come back during or after previous treatme...

A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

NCT ID: NCT05789069

This clinical trial is studying a new treatment called HFB200603, both on its own and in combination with another medication called tislelizumab, for adult patients with advanced cancers such as re...

89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma

NCT ID: NCT04006522

This clinical trial is exploring a specialized imaging technique called 89Zr-DFO-Atezolizumab ImmunoPET/CT to see how well it can help doctors understand renal cell carcinoma (RCC), a type of kidne...

Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma

NCT ID: NCT06318871

This clinical trial is exploring a new type of treatment for patients with advanced kidney cancer (renal cell carcinoma) and bladder cancer (urothelial carcinoma). The focus is on using a special k...

Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)

NCT ID: NCT05056077

This clinical trial, called "Tools To Be Fit," is exploring how different support tools can help cancer survivors improve their nutrition, physical activity, and overall health after treatment. Res...

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

NCT ID: NCT05078047

This clinical trial is investigating whether a less frequent administration of immunotherapy (IO) can be just as effective as the standard treatment schedule for patients with certain types of adva...

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

NCT ID: NCT06682793

This clinical trial is testing a new treatment called A2B395 for patients with certain types of solid tumors, such as colorectal cancer, lung cancer, and triple-negative breast cancer. The main goa...

Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma

NCT ID: NCT07018037

This clinical trial is looking at a virus called torquetenovirus (TTV) to see if it can help doctors understand how well certain immunotherapy treatments work for patients with advanced kidney canc...

National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)

NCT ID: NCT05326620

The PRO-RCC trial is a nationwide study focused on patients with renal cell carcinoma (RCC), which is a type of kidney cancer. The goal of this trial is to collect real-world information about pati...

Phase 2 Study of Lenvatinib Plus Pembrolizumab in IO Refractory mRCC Patients With Brain Metastases

NCT ID: NCT07011849

This clinical trial is investigating the combination of two medications, lenvatinib and pembrolizumab, to see how well they work together in treating patients with advanced kidney cancer (renal cel...